Form D · Biotechnology

Concerto Biosciences, Inc.

Allston, MA · CIK 0001918491

Offering snapshot reported Jun 16, 2022 · SEC filing

Reported sold
$24.5M
Offering amount: $24.5M
Investors reported
37
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 8, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12.3M$24.5MMar 23, 2022: $16,031,971.00Mar 23, 2022Jun 16, 2022: $24,541,949.00Jun 16, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$16,031,971 → $24,541,949
  • Reported investors27 → 37

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 16, 2022Amendment$24,541,949$8,509,978vs Mar 23, 202237SEC filing
Mar 23, 2022Initial$16,031,971No comparison27SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-438545

Source: Form D, filed Jun 16, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cheri Ackerman Director, Executive
Bernardo Cervantes Director, Executive
Jared Kehe Director, Executive
Sarah Luppino Director
Vera Schroeder Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
127 Western Ave
Allston, MA, 02134